Search Results

81 - 82 of 82 items :

  • pharmacokinetics x
  • Life Sciences x
Clear All
Radiology of the adrenal incidentalomas. Review of the literature

. Unal E, Karaosmanoglu A, Akata D, Ozmen MN, Karcaaltincaba M. Invisible fat on CT: making it visible by MRI. Diagn Interv Radiol 22, 133-140, 2016. van Niel MB, Collins I, Beer MS, Broughton HB, Cheng SK, Goodacre SC, Heald A, Locker KL, MacLeod AM, Morrison D, Moyes CR, O’Connor D, Pike A, Rowley M, Russell MG, Sohal B, Stanton JA, Th omas S, Verrier H, Watt AP, Castro JL. Fluorination of 3-(3-(piperidin-1-yl) propyl) indoles and 3-(3-(piperazin-1-yl) propyl) indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profi

Open access
Novel insights into genetics and clinics of the HNF1A-MODY

subtypes. Diabetologia 54, 2801–2810, 2011. Tzvetkov MV, Saadatmand AR, Bokelmann K, Meineke I, Kaiser R, Brockmoller J. Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron. Pharmacogenomics J 12, 22–29, 2012. Tzvetkov MV, Saadatmand AR, Lotsch J, Tegeder I, Stingl JC, Brockmoller J. Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug Tramadol. Clin Pharmacol Ther 90, 143–150, 2011

Open access